- Category : Healthcare
- Region : Global
- Publishing Date : 07/01/2021
Global Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Region: Trend Outlook and Growth Opportunity
Global biosurgery market will reach $21.55 billion by 2027, growing by 6.6% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.
Highlighted with 83 tables and 82 figures, this 155-page report “Global Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hemostatic Agents
• Bone-graft Substitutes
o Synthetic Graft Extender
o Demineralized Bone Matrix
o Bone Morphogenetic Proteins
o Cell-Based Matrices
• Surgical Sealants and Adhesives
o Natural Surgical Sealing Agents
o Synthetic Surgical Sealing Agents
• Soft-tissue Attachments
o Natural & Biological Mesh/Patch
o Synthetic Mesh/Patch
• Adhesion Barriers
o Natural Adhesion Barriers
o Synthetic Adhesion Barriers
• Staple Line Reinforcement
Based on Source Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Other Applications
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Product, Source Type, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Global Market by Product 39
3.1 Market Overview by Product 39
3.2 Hemostatic Agents 41
3.3 Bone-graft Substitutes 42
3.2.1 Synthetic Graft Extender 43
3.2.2 Demineralized Bone Matrix 44
3.2.3 Bone Morphogenetic Proteins 45
3.2.4 Cell-Based Matrices 46
3.4 Surgical Sealants and Adhesives 47
3.4.1 Natural Surgical Sealing Agents 48
3.4.2 Synthetic Surgical Sealing Agents 49
3.5 Soft-tissue Attachments 50
3.5.1 Natural & Biological Mesh/Patch 51
3.5.2 Synthetic Mesh/Patch 52
3.6 Adhesion Barriers 53
3.6.1 Natural Adhesion Barriers 54
3.6.2 Synthetic Adhesion Barriers 55
3.7 Staple Line Reinforcement 56
4 Segmentation of Global Market by Source Type 57
4.1 Market Overview by Source Type 57
4.2 Natural/Biological Products 59
4.3 Synthetic Products 60
5 Segmentation of Global Market by Application 62
5.1 Market Overview by Application 62
5.2 Orthopedic Surgery 64
5.3 General Surgery 65
5.4 Neurological Surgery 66
5.5 Cardiovascular Surgery 67
5.6 Gynecological Surgery 68
5.7 Other Applications 69
6 Segmentation of Global Market by Region 70
6.1 Geographic Market Overview 2020-2027 70
6.2 North America Market 2020-2027 by Country 74
6.2.1 Overview of North America Market 74
6.2.2 U.S. 77
6.2.3 Canada 80
6.2.4 Mexico 82
6.3 European Market 2020-2027 by Country 84
6.3.1 Overview of European Market 84
6.3.2 UK 87
6.3.3 France 89
6.3.4 Germany 91
6.3.5 Spain 93
6.3.6 Italy 95
6.3.7 Russia 97
6.3.8 Rest of European Market 99
6.4 Asia-Pacific Market 2020-2027 by Country 101
6.4.1 Overview of Asia-Pacific Market 101
6.4.2 China 104
6.4.3 Japan 106
6.4.4 India 109
6.4.5 Australia 111
6.4.6 South Korea 113
6.4.7 Rest of APAC Region 115
6.5 South America Market 2020-2027 by Country 117
6.5.1 Argentina 120
6.5.2 Brazil 122
6.5.3 Chile 124
6.5.4 Rest of South America Market 126
6.6 MEA Market 2020-2027 by Country 127
6.6.1 UAE 130
6.6.2 Saudi Arabia 132
6.6.3 South Africa 134
6.6.4 Other National Markets 136
7 Competitive Landscape 137
7.1 Overview of Key Vendors 137
7.2 New Product Launch, Partnership, Investment, and M&A 140
7.3 Company Profiles 141
B. Braun Melsungen AG 141
Baxter International, Inc. 143
Becton, Dickinson and Company (C.R. Bard) 144
Betatech Medical 145
CryoLife Inc. 146
CSL Limited 147
Hemostasis LLC 148
Integra Lifesciences Holdings Corporation 149
Johnson & Johnson 150
Medtronic PLC 151
Pfizer, Inc. 152
Sanofi S.A. 153
Stryker Corporation 154
RELATED REPORTS 155